SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Sep-24 5:17 PM View: | Eli Lilly & Co. (LLY) | 16-Sep-24 | Grant | 16 | $923.54 | $14,776.60 | < 1% 15.79K to 15.81K | |
04-Sep-24 4:31 PM View: | Archer-Daniels-Midland Co. (ADM) | 03-Sep-24 | Option Exercise | 170,194 | $46.92 | $7,985,500.00 | 10% 1.76M to 1.93M | |
04-Sep-24 4:31 PM View: | Archer-Daniels-Midland Co. (ADM) | 03-Sep-24 | Option Sale | 170,194 | $60.51 | $10,298,800.00 | (9%) 1.93M to 1.76M | |
04-Sep-24 8:05 AM View: | Archer-Daniels-Midland Co. (ADM) | 30-Aug-24 | Option Exercise | 45,471 | $46.92 | $2,133,500.00 | 3% 1.76M to 1.8M | |
04-Sep-24 8:05 AM View: | Archer-Daniels-Midland Co. (ADM) | 30-Aug-24 | Option Sale | 45,471 | $61.00 | $2,773,920.00 | (3%) 1.8M to 1.76M | |
30-Aug-24 4:23 PM View: | Archer-Daniels-Midland Co. (ADM) | 29-Aug-24 | Option Exercise | 99,752 | $46.92 | $4,680,360.00 | 6% 1.76M to 1.86M | |
30-Aug-24 4:23 PM View: | Archer-Daniels-Midland Co. (ADM) | 29-Aug-24 | Option Sale | 99,752 | $61.05 | $6,090,200.00 | (5%) 1.86M to 1.76M | |
29-Aug-24 4:53 PM View: | Archer-Daniels-Midland Co. (ADM) | 28-Aug-24 | Option Exercise | 3,683 | $46.92 | $172,806.00 | < 1% 1.76M to 1.76M | |
29-Aug-24 4:53 PM View: | Archer-Daniels-Midland Co. (ADM) | 28-Aug-24 | Option Sale | 3,683 | $61.00 | $224,673.00 | (< 1%) 1.76M to 1.76M | |
27-Aug-24 4:22 PM View: | Archer-Daniels-Midland Co. (ADM) | 26-Aug-24 | Option Exercise | 5,721 | $46.92 | $268,429.00 | < 1% 1.76M to 1.76M | |
27-Aug-24 4:22 PM View: | Archer-Daniels-Midland Co. (ADM) | 26-Aug-24 | Option Sale | 5,721 | $61.01 | $349,011.00 | (< 1%) 1.76M to 1.76M | |
20-Aug-24 4:17 PM View: | Eli Lilly & Co. (LLY) | 19-Aug-24 | Grant | 16 | $921.81 | $14,749.00 | < 1% 15.75K to 15.77K | |
16-Jul-24 4:21 PM View: | Eli Lilly & Co. (LLY) | 15-Jul-24 | Grant | 16 | $950.46 | $15,207.40 | < 1% 15.74K to 15.75K | |
18-Jun-24 4:22 PM View: | Eli Lilly & Co. (LLY) | 17-Jun-24 | Grant | 17 | $885.01 | $15,045.20 | < 1% 15.72K to 15.74K | |
29-May-24 4:23 PM View: | Archer-Daniels-Midland Co. (ADM) | 28-May-24 | Gift | 182,501 | -- | -- | 10% 1.76M to 1.94M | |
29-May-24 4:23 PM View: | Archer-Daniels-Midland Co. (ADM) | 28-May-24 | Gift | 182,501 | -- | -- | (9%) 1.94M to 1.76M | |
21-May-24 4:23 PM View: | Eli Lilly & Co. (LLY) | 20-May-24 | Grant | 19 | $783.18 | $14,880.40 | < 1% 15.68K to 15.7K | |
16-Apr-24 4:13 PM View: | Eli Lilly & Co. (LLY) | 15-Apr-24 | Grant | 20 | $750.77 | $15,015.40 | < 1% 15.66K to 15.68K | |
22-Mar-24 4:25 PM View: | Archer-Daniels-Midland Co. (ADM) | 21-Mar-24 | Payment of Exercise | 64,830 | $59.31 | $3,845,070.00 | (4%) 1.82M to 1.76M | |
22-Mar-24 4:25 PM View: | Archer-Daniels-Midland Co. (ADM) | 20-Mar-24 | Grant | 115,479 | -- | -- | 6% 1.78M to 1.9M | |
22-Mar-24 4:25 PM View: | Archer-Daniels-Midland Co. (ADM) | 20-Mar-24 | Payment of Exercise | 75,220 | $53.00 | $3,986,780.00 | (4%) 1.9M to 1.82M | |
20-Mar-24 5:24 PM View: | Archer-Daniels-Midland Co. (ADM) | 18-Mar-24 | Grant | 146,342 | -- | -- | 9% 1.64M to 1.78M | |
19-Mar-24 4:21 PM View: | Eli Lilly & Co. (LLY) | 18-Mar-24 | Grant | 19 | $762.66 | $14,490.50 | < 1% 15.64K to 15.66K | |
21-Feb-24 4:21 PM View: | Eli Lilly & Co. (LLY) | 20-Feb-24 | Grant | 20 | $755.66 | $15,113.20 | < 1% 15.59K to 15.61K | |
17-Jan-24 4:17 PM View: | Eli Lilly & Co. (LLY) | 16-Jan-24 | Grant | 23 | $634.57 | $14,595.10 | < 1% 15.57K to 15.59K | |
19-Dec-23 4:15 PM View: | Eli Lilly & Co. (LLY) | 18-Dec-23 | Grant | 25 | $579.76 | $14,494.00 | < 1% 15.54K to 15.57K | |
21-Nov-23 4:27 PM View: | Eli Lilly & Co. (LLY) | 20-Nov-23 | Grant | 359 | $597.60 | $214,538.00 | 2% 15.16K to 15.52K | |
17-Oct-23 4:22 PM View: | Eli Lilly & Co. (LLY) | 16-Oct-23 | Grant | 23 | $616.64 | $14,182.70 | < 1% 15.13K to 15.16K | |
20-Sep-23 4:28 PM View: | Eli Lilly & Co. (LLY) | 18-Sep-23 | Grant | 25 | $571.28 | $14,282.00 | < 1% 15.11K to 15.13K | |
22-Aug-23 4:31 PM View: | Eli Lilly & Co. (LLY) | 21-Aug-23 | Grant | 26 | $550.50 | $14,313.00 | < 1% 15.05K to 15.08K | |
18-Jul-23 4:40 PM View: | Eli Lilly & Co. (LLY) | 17-Jul-23 | Grant | 32 | $447.14 | $14,308.50 | < 1% 15.02K to 15.05K | |
21-Jun-23 4:27 PM View: | Eli Lilly & Co. (LLY) | 20-Jun-23 | Grant | 32 | $451.95 | $14,462.40 | < 1% 14.99K to 15.02K | |
16-May-23 4:28 PM View: | Eli Lilly & Co. (LLY) | 15-May-23 | Grant | 33 | $434.51 | $14,338.80 | < 1% 14.92K to 14.95K | |
19-Apr-23 4:31 PM View: | Eli Lilly & Co. (LLY) | 17-Apr-23 | Grant | 39 | $372.35 | $14,521.70 | < 1% 14.88K to 14.92K | |
22-Mar-23 4:14 PM View: | Eli Lilly & Co. (LLY) | 20-Mar-23 | Grant | 43 | $333.60 | $14,344.80 | < 1% 14.84K to 14.88K | |
03-Mar-23 4:17 PM View: | Archer-Daniels-Midland Co. (ADM) | 02-Mar-23 | Gift | 291,999 | -- | -- | 18% 1.64M to 1.93M | |
03-Mar-23 4:17 PM View: | Archer-Daniels-Midland Co. (ADM) | 02-Mar-23 | Gift | 291,999 | -- | -- | (15%) 1.93M to 1.64M | |
15-Feb-23 4:17 PM View: | Archer-Daniels-Midland Co. (ADM) | 13-Feb-23 | Payment of Exercise | 232,233 | $82.09 | $19,064,000.00 | (12%) 1.87M to 1.64M | |
10-Feb-23 5:52 PM View: | Archer-Daniels-Midland Co. (ADM) | 09-Feb-23 | Grant | 87,842 | -- | -- | 5% 1.78M to 1.87M | |
26-Jan-23 6:19 PM View: | Archer-Daniels-Midland Co. (ADM) | 25-Jan-23 | Grant | 349,488 | -- | -- | 24% 1.43M to 1.78M | |
19-Jan-23 4:42 PM View: | Eli Lilly & Co. (LLY) | 17-Jan-23 | Grant | 40 | $357.74 | $14,309.60 | < 1% 14.7K to 14.74K | |
20-Dec-22 5:14 PM View: | Eli Lilly & Co. (LLY) | 19-Dec-22 | Grant | 39 | $357.78 | $13,953.40 | < 1% 14.66K to 14.7K | |
22-Nov-22 5:38 PM View: | Eli Lilly & Co. (LLY) | 21-Nov-22 | Grant | 537 | $361.17 | $193,948.00 | 4% 14.09K to 14.62K | |
27-Oct-22 4:32 PM View: | Archer-Daniels-Midland Co. (ADM) | 26-Oct-22 | Option Exercise | 300,000 | $33.18 | $9,954,000.00 | 21% 1.43M to 1.73M | |
27-Oct-22 4:32 PM View: | Archer-Daniels-Midland Co. (ADM) | 26-Oct-22 | Planned Option Sale | 300,000 | $93.38 | $28,014,600.00 | (17%) 1.73M to 1.43M | |
19-Oct-22 4:21 PM View: | Eli Lilly & Co. (LLY) | 17-Oct-22 | Grant | 42 | $332.76 | $13,975.90 | < 1% 14.04K to 14.09K | |
21-Sep-22 4:44 PM View: | Eli Lilly & Co. (LLY) | 19-Sep-22 | Grant | 46 | $305.09 | $14,034.10 | < 1% 14.0K to 14.04K | |
12-Sep-22 4:18 PM View: | Archer-Daniels-Midland Co. (ADM) | 09-Sep-22 | Option Exercise | 284,531 | $39.34 | $11,192,700.00 | 20% 1.43M to 1.72M | |
12-Sep-22 4:18 PM View: | Archer-Daniels-Midland Co. (ADM) | 09-Sep-22 | Planned Option Sale | 284,531 | $91.20 | $25,949,000.00 | (17%) 1.72M to 1.43M | |
16-Aug-22 4:24 PM View: | Eli Lilly & Co. (LLY) | 15-Aug-22 | Grant | 45 | $313.94 | $14,127.30 | < 1% 13.91K to 13.95K |